PIRS Old Financials

PIRS Old Stock Summary

PIRS Old competes with Adaptimmune Therapeutics, Mereo BioPharma, PDS Biotechnology, Leap Therapeutics, and X4 Pharmaceuticals. Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts. Pieris Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people.

PIRS Old Key Financial Ratios

PIRS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PIRS Old's current stock value. Our valuation model uses many indicators to compare PIRS Old value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PIRS Old competition to find correlations between indicators driving PIRS Old's intrinsic value. More Info.PIRS Old is rated below average in return on equity category among its peers. It is regarded third in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value PIRS Old by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

If you are still planning to invest in PIRS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PIRS Old's history and understand the potential risks before investing.